Search research articles
Contact Us
Filters
Showing results (51-60 of 172) with videos related to
Page
of 18
Sort By:
Clinical Immunology (Orlando, Fla.)
|
June 20, 2012
Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers
Karina Ramirez, Rezwanul Wahid, Charles Richardson, et al.
Plos Neglected Tropical Diseases
|
August 21, 2019
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis
Theresa B Gallagher, Gabriela Mellado-Sanchez, Ana L Jorgensen, et al.
Vaccine
|
September 23, 2008
Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy
Leslie W J Baillie, Ana L Rodriguez, Stephen Moore, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 20, 2006
Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies
Alejandra V E Capozzo, Karina Ramírez, John M Polo, et al.
Vaccine
|
March 1, 2008
An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes
Marcela F Pasetti, Lilian Cuberos, Thomas L Horn, et al.
Vaccine
|
February 1, 2022
Measles susceptibility in maternal-infant dyads-Bamako, Mali
Meredith G Dixon, Milagritos D Tapia, Kathleen Wannemuehler, et al.
Clinical and Vaccine Immunology : CVI
|
December 9, 2016
Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study
Avital A Shimanovich, Amanda D Buskirk, Shannon J Heine, et al.
JCI Insight
|
July 13, 2018
Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial
Leesun Kim, David Liebowitz, Karen Lin, et al.
Plos Neglected Tropical Diseases
|
November 10, 2011
Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines
Orit Gat, James E Galen, Sharon Tennant, et al.
Msphere
|
April 5, 2023
A Novel <i>Shigella</i> O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple <i>Shigella</i> Serotypes
Girmay Desalegn, Neeraj Kapoor, Lucy Pill-Pepe, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 172) with videos related to
Sort By:
Page
of 18
Clinical Immunology (Orlando, Fla.)
|
June 20, 2012
Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers
Karina Ramirez, Rezwanul Wahid, Charles Richardson, et al.
Plos Neglected Tropical Diseases
|
August 21, 2019
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis
Theresa B Gallagher, Gabriela Mellado-Sanchez, Ana L Jorgensen, et al.
Vaccine
|
September 23, 2008
Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy
Leslie W J Baillie, Ana L Rodriguez, Stephen Moore, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 20, 2006
Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies
Alejandra V E Capozzo, Karina Ramírez, John M Polo, et al.
Vaccine
|
March 1, 2008
An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes
Marcela F Pasetti, Lilian Cuberos, Thomas L Horn, et al.
Vaccine
|
February 1, 2022
Measles susceptibility in maternal-infant dyads-Bamako, Mali
Meredith G Dixon, Milagritos D Tapia, Kathleen Wannemuehler, et al.
Clinical and Vaccine Immunology : CVI
|
December 9, 2016
Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study
Avital A Shimanovich, Amanda D Buskirk, Shannon J Heine, et al.
JCI Insight
|
July 13, 2018
Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial
Leesun Kim, David Liebowitz, Karen Lin, et al.
Plos Neglected Tropical Diseases
|
November 10, 2011
Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines
Orit Gat, James E Galen, Sharon Tennant, et al.
Msphere
|
April 5, 2023
A Novel <i>Shigella</i> O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple <i>Shigella</i> Serotypes
Girmay Desalegn, Neeraj Kapoor, Lucy Pill-Pepe, et al.
Page
of 18